Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
28/11/2018
28/11/2018
27/11/2018
07/11/2018
05/11/2018
26/10/2018
18/10/2018
12/10/2018
02/10/2018
01/10/2018
28/09/2018
26/09/2018
25/09/2018
25/09/2018
20/09/2018
20/09/2018
20/09/2018
18/09/2018
14/09/2018
16/09/2019
13/09/2018
11/09/2018
07/09/2018
04/09/2018
04/09/2018
21/08/2018
20/08/2018
17/08/2018
03/08/2018
01/08/2018
01/08/2018
16/07/2018
06/07/2018
26/06/2018
26/06/2018
25/06/2018
22/06/2018
01/03/2017
06/03/2018
28/08/2019
30/08/2017
08/08/2019
05/08/2019
02/08/2019